GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JiangXi Tianxin Pharmaceutical Co Ltd (SHSE:603235) » Definitions » Debt-to-Equity

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Debt-to-Equity : 0.05 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is JiangXi Tianxin Pharmaceutical Co Debt-to-Equity?

JiangXi Tianxin Pharmaceutical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥223 Mil. JiangXi Tianxin Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥4 Mil. JiangXi Tianxin Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥4,355 Mil. JiangXi Tianxin Pharmaceutical Co's debt to equity for the quarter that ended in Mar. 2024 was 0.05.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for JiangXi Tianxin Pharmaceutical Co's Debt-to-Equity or its related term are showing as below:

SHSE:603235' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.07   Max: 0.31
Current: 0.05

During the past 6 years, the highest Debt-to-Equity Ratio of JiangXi Tianxin Pharmaceutical Co was 0.31. The lowest was 0.00. And the median was 0.07.

SHSE:603235's Debt-to-Equity is ranked better than
88.74% of 1643 companies
in the Consumer Packaged Goods industry
Industry Median: 0.41 vs SHSE:603235: 0.05

JiangXi Tianxin Pharmaceutical Co Debt-to-Equity Historical Data

The historical data trend for JiangXi Tianxin Pharmaceutical Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JiangXi Tianxin Pharmaceutical Co Debt-to-Equity Chart

JiangXi Tianxin Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial 0.24 0.31 0.18 - 0.03

JiangXi Tianxin Pharmaceutical Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.03 0.03 0.03 0.05

Competitive Comparison of JiangXi Tianxin Pharmaceutical Co's Debt-to-Equity

For the Packaged Foods subindustry, JiangXi Tianxin Pharmaceutical Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JiangXi Tianxin Pharmaceutical Co's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JiangXi Tianxin Pharmaceutical Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where JiangXi Tianxin Pharmaceutical Co's Debt-to-Equity falls into.



JiangXi Tianxin Pharmaceutical Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

JiangXi Tianxin Pharmaceutical Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

JiangXi Tianxin Pharmaceutical Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JiangXi Tianxin Pharmaceutical Co  (SHSE:603235) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


JiangXi Tianxin Pharmaceutical Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of JiangXi Tianxin Pharmaceutical Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Business Description

Traded in Other Exchanges
N/A
Address
Le'anjiang Industrial Park, Jiangxi Province, Leping, CHN, 333300
JiangXi Tianxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of monomeric vitamin products.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Headlines

No Headlines